Shares of Fusion Pharmaceuticals Inc. (NASDAQ:FUSN – Get Rating) have earned an average recommendation of “Buy” from the eight research firms that are currently covering the stock, Marketbeat Ratings reports. Eight analysts have rated the stock with a buy recommendation. The average twelve-month price target among brokerages that have covered the stock in the last […]
Shares of Fusion Pharmaceuticals Inc. (NASDAQ:FUSN – Get Rating) have earned a consensus rating of “Buy” from the eight research firms that are covering the stock, MarketBeat.com reports. Eight investment analysts have rated the stock with a buy recommendation. The average 12 month price objective among brokers that have issued ratings on the stock in […]
Shares of Fusion Pharmaceuticals Inc. (NASDAQ:FUSN – Get Rating) have earned an average rating of “Buy” from the eight research firms that are currently covering the company, Marketbeat reports. Eight investment analysts have rated the stock with a buy recommendation. The average 1-year target price among brokers that have covered the stock in the last […]
B. Riley reiterated their buy rating on shares of Fusion Pharmaceuticals (NASDAQ:FUSN – Get Rating) in a research note released on Thursday, Benzinga reports. They currently have a $10.00 price target on the stock. Several other equities research analysts have also issued reports on FUSN. Morgan Stanley dropped their price objective on Fusion Pharmaceuticals from […]
B. Riley reaffirmed their buy rating on shares of Fusion Pharmaceuticals (NASDAQ:FUSN – Get Rating) in a research report report published on Thursday, Benzinga reports. They currently have a $10.00 price objective on the stock. A number of other brokerages also recently issued reports on FUSN. Morgan Stanley cut their price objective on shares of […]